-
Conference Preview: The 11th Sino-French Hematology Summit of the Chinese Medical Doctor Association will be held in Tianjin in mid-September
The “11th Sino-French Hematology Summit of the Chinese Medical Doctor Association,” organized by the Chinese Medical Doctor Association, the Hematology Branch of the Chinese Medical Doctor Association, and the French Hematology Association, and hosted by the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of Medical…
-
News Express | Blossoms on the Path to Cancer Cure: The Remarkable Journey of Vinca Alkaloids
The “News Express” column serves as a bridge between cutting-edge research and clinical practice, enabling hematology enthusiasts and professionals to swiftly capture industry dynamics, ignite innovative thinking, and broaden their professional perspectives. Hematology Frontier carefully selects the latest hematological research findings from top global journals. Each article is a brilliant spark of science and clinical…
-
Interventional Therapy in Hepatobiliary Diseases丨Dr. Xuefeng Luo: In-Depth Analysis of the French Guidelines on Transjugular Intrahepatic Portosystemi
Editor’s Note: Interventional therapy is an emerging clinical discipline that forms a crucial part of minimally invasive medicine, standing alongside traditional internal medicine and surgery as a key clinical specialty.…
-
Medical Insights with SIFIC丨Undiminished Passion, Boundless Exploration—Together, We Embark on a New Chapter in Infection Control
Editor’s Note: Over the past two decades, SIFIC has witnessed a remarkable transformation in the field of infection control, evolving from evidence-based practices to precision strategies, all while maintaining an…
-
Dr. Yaokai Chen’s Team: Prevalence of Cryptococcal Antigenemia and the Effectiveness of Prophylactic Fluconazole Treatment in HIV-Infected Individuals
Editor’s Note: At the 25th International AIDS Conference (AIDS2024), an event that commands global attention, the Chongqing Public Health Medical Center once again shone on the international stage with its…
-
Dr. Jian Hou: Treatment of Multiple Myeloma – Coexisting Challenges and Opportunities | The 8th CSCO Hematology Academic Conference
The 8th Hematology Academic Conference, organized by the Chinese Society of Clinical Oncology (CSCO), CSCO Leukemia Expert Committee, and CSCO Lymphoma Expert Committee, and co-hosted by Harbin Institute of Hematology and Oncology and Peking University Cancer Hospital, was grandly held in Harbin from July 26 to 28, 2024. On this occasion, “Oncology Frontier – Hematology…
-
ASCO 2024 | PostMONARCH Primary Outcomes Released: Abemaciclib + Fulvestrant Continues to Benefit CDK4/6-Pretreated HR+/HER2- Advanced Breast Cancer
PostMONARCH is the first randomized, placebo-controlled phase III study of its kind. At the 2024 ASCO conference, Dr. Kevin Kalinsky from the Winship Cancer Institute of Emory University presented the primary outcomes of the PostMONARCH study, revealing that continued treatment with abemaciclib (Abemaciclib) + fulvestrant benefits patients even after progression on CDK4/6 inhibitor therapy. This…
-
EHA Global Insights | Dr. Michael Wang Interprets the Latest Results from the ECHO Clinical Trial
Mantle cell lymphoma (MCL) is an aggressive lymphoma with high malignancy and poor treatment outcomes, especially for elderly patients or those in poor health. Optimizing treatment regimens for these patient groups is crucial. At the recent 29th European Hematology Association (EHA) annual meeting, Dr. Michael Wang from University of Texas MD Anderson, Houston, USA presented…
Connecting Medical Expertise through Media